A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve

Gynecological Endocrinology

Volumn 29, Issue 11, 2013, Pages 989-992

  Singh, Neeta ^a   Zangmo, Rinchen ^a   Kumar, Sunesh ^a   Roy, K K ^a   Sharma, J B ^a   Malhotra, Neena ^a   Vanamail, Perumal ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antimullerian hormone; Antral follicle count; Dehydroepiandrosterone; Estradiol; Poor ovarian reserve

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LEUPRORELIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PRASTERONE; RECOMBINANT FOLLITROPIN; TAB EEMA D; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GROUPS BY AGE; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT FAILURE;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INDIA; INFERTILITY, FEMALE; OVARIAN FOLLICLE; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

EID: 84885069576     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.824957     Document Type: Article

References (11)

1. Wiser A, Goner O, Ghetler Y, et al. Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 2010; 25: 2496-500.
2. Kailasam C, Keay SD, Wilson P, et al. Defining poor ovarian response during IVF cycles, in women aged 40 years, and its relationship with treatment outcome. Hum Reprod 2004; 19: 1544-7.
3. Ulug U, Ben-Shlomo I, Turan E, et al. Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online 2003; 6: 439-43.
4. Mohamed KA, Davies WA, Allsopp J, Lashen H. Agonist flare-up' versus antagonist in the management of poor responders undergoing in vitro fertilization treatment. Fertil Steril 2005; 83: 331-5.
5. Schmidt DW, Bremner T, Orris JJ, et al. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 2005; 83: 1568-71.
6. Frattarelli JL, Hill MJ, McWilliams GD, et al. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008; 89: 1118-22.
7. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006; 21: 2845-9.
8. Casson PR, Lindsay M, Pisarka M. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000; 15: 2129-32.
9. Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil Steril 2009; 91: 644-6.
10. Gleicher N, Weghofer A, Barad DH. Anti-Mu llerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 2010; 94: 2824-7.
11. Barad DH, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005; 84: 30-2.